http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_9b6db2fed7a8bf30b4c2ee4ecb4e2693
Outgoing Links
| Predicate | Object |
|---|---|
| family-name | Kopetz |
| name | Scott Kopetz |
| given-name | Scott |
| organization-name | Emil Lou, MD, PhD, Masonic Cancer Center, University of Minnesota, Minneapolis, MN; Muhammad Shaalan Beg, MD, University of Texas Southwestern Medical Center, Dallas, TX; Emily Bergsland, MD, University of California San Francisco, San Francisco, CA; Cathy Eng, MD, Vanderbilt-Ingram Cancer Center, Nashville, TN; Alok A. Khorana, MD, Cleveland Clinic, Cleveland, OH; Scott Kopetz, MD, PhD, University of Texas MD Anderson Cancer Center, Houston, TX; Sam Lubner, MD, University of Wisconsin, Madison, WI;... From the University of Texas M.D. Anderson Cancer Center, Houston (S.K., V.M.); West Cancer Center and Research Institute, OneOncology, Germantown, TN (A. Grothey); Memorial Sloan Kettering Cancer Center, New York (R.Y., A.K.); University Hospital Gasthuisberg and University of Leuven, Leuven, Belgium (E.V.C., J. Dekervel); the Peter MacCallum Cancer Centre, Melbourne, VIC, Australia (J. Desai, C.G.); National Cancer Center Hospital East, Kashiwa, Japan (T.Y.); Hammersmith Hospital, Division of Cancer,... Department of Gastrointestinal Medical Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, TX. Department of Gastrointestinal Medical Oncology, The University of Texas M.D. Anderson Cancer Center, Houston, TX, USA Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas. 1Department of Gastrointestinal Medical Oncology, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas. Department of Gastrointestinal Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA Department of Gastrointestinal Medical Oncology, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas. Authors' Affiliation: Department of Gastrointestinal Medical Oncology, The University of Texas, M. D. Anderson Cancer Center, Houston, Texas 6Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas. The University of Texas MD Anderson Cancer Center 8Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas. Authors' Affiliations: Departments of 1Gastrointestinal Medical Oncology, 2Genitourinary Medical Oncology, 3Experimental Therapeutics, 4Melanoma Medical Oncology, 5Thoracic/Head and Neck Medical Oncology, 6Systems Biology, and 7Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, and Graduate School of Biomedical Sciences, University of Texas, Houston, Texas; 8Ludwig Institute for Cancer Research; 9Royal Melbourne Hospital and Peter MacCallum Cancer Institute, Ludwig Institute for Cancer Research, Melbourne, Australia; and 10Plexxikon Inc., Berkeley, California Department of GI Medical Oncology University of Texas MD Anderson Cancer Center, Houston, TX Kanwal Raghav, Jonathan M. Loree, Jeffrey S. Morris, Michael J. Overman, Ruoxi Yu, Funda Meric-Bernstam, David Menter, Krittiya Korphaisarn, Brian Kee, Mark Routbort, Ken Chen, Kenna R.M. Shaw, Riham Katkhuda, Dipen Maru, and Scott Kopetz, The University of Texas MD Anderson Cancer Center, Houston, TX; Andrea Muranyi, Shalini Singh, and Kandavel Shanmugam, Ventana Medical Systems, Tucson, AZ; and Marwan Fakih, City of Hope Comprehensive Cancer Center, Duarte, CA. Department of Gastrointestinal Medical Oncology, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX Department of Gastrointestinal Medical Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, TX, USA Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA From the Departments of Gastrointestinal Medical Oncology and Surgical Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, TX; and Departments of Health Sciences Research, Surgery, and Oncology, Mayo Clinic, Rochester, MN. Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, 1400 Holcombe Blvd, Houston, TX 77030, USA 5Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas. From the Departments of Surgical Oncology, Cancer Biology, Biostatistics, and Cancer Medicine, The University of Texas M. D. Anderson Cancer Center, Houston, TX Division of Cancer Medicine, Department of Gastrointestinal Medical Oncology The University of Texas MD Anderson Cancer Center Houston Texas The University of Texas MD Anderson Cancer Center, Houston, Texas. Authors' Affiliations: Departments of 1Investigational Cancer Therapeutics (Phase I Program), 2Gastrointestinal Medical Oncology, 3NeuroSurgery, and 4Neuro Oncology, and 5Neurofibromatosis Working Group, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas The University of Texas MD Anderson Cancer Center, Houston, TX The University of Texas MD Anderson Cancer Center, Houston, Texas, USA Gastrointestinal Medical Oncology, University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Unit 426, Houston, TX 77030, USA. Department of Gastrointestinal Medical Oncology University of Texas MD Anderson Cancer Center Houston, TX. Department of Gastrointestinal Medical Oncology, The University of Texas M.D. Anderson Cancer Center, Houston, Texas 77030, USA. [email protected] Authors' Affiliation: Department of Gastrointestinal Medical Oncology and Experimental Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, Texas University of Texas MD Anderson Cancer Center, Houston, Texas, USA Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center Houston Texas Department of Gastrointestinal Medical Oncology The University of Texas MD Anderson Cancer Center Houston Texas USA From the Departments of Gastrointestinal Medical Oncology and Clinical Cancer Prevention, The University of Texas M.D. Anderson Cancer Center, Houston, TX Authors' Affiliations: Department of 1Urology, 2Medical Oncology, 3Pathology, 4Cancer Therapy and Research Center, 5South Texas Veterans Health Care System, The University of Texas Health Science Center, San Antonio; 6Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston; and 7Department of carcinogenesis, The University of Texas MD Anderson Cancer Center, Smithville, Texas Department of Gastrointestinal (GI) Medical Oncology, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas; MD Anderson Cancer Center Houston TX USA Departments of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA; Department of Gastrointestinal Medical Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, TX Scott Kopetz, Dipen Maru, Van Morris, Filip Janku, and Arvind Dasari, The University of Texas MD Anderson Cancer Center, Houston, TX; Emily Chan, Vanderbilt-Ingram Cancer Center, Nashville, TN; Joel Randolph Hecht, David Geffen School of Medicine at University of California, Los Angeles, Los Angeles; Brian James and Garth Powis, Sanford Burnham Institute, La Jolla; Keith B. Nolop, Plexxikon, Berkeley; Suman Bhattacharya, Genentech, South San Francisco, CA; Peter J. O'Dwyer, Abramson Cancer Center at... Department of Gastrointestinal Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas Department of Gastrointestinal Medical Oncology, The University of Texas, M D Anderson Cancer Center, Houston 77030, USA. Gastrointestinal Medical Oncology, MD Anderson Cancer Center, University of Texas, Austin, TX From the Departments of Gastrointestinal Medical Oncology, Pathology, Diagnostic Radiology, and Surgical Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, TX; and the Centro Oncologico de Hospital Sirio-Libanes, São Paulo, Brazil. From the Department of Gastrointestinal Medical Oncology, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX. From the Department of Gastrointestinal Medical Oncology; and the Department of Biostatistics and Applied Mathematics, The University of Texas M. D. Anderson Cancer Center, Houston, TX. Department of Gastrointestinal Medical Oncology The University of Texas MD Anderson Cancer Center Houston TX 77030 USA 1The Graduate School of Biomedical Sciences, The University of Texas Health Science Center at Houston, Houston, Texas.; 3Department of Gastrointestinal Medical Oncology, The University of Texas M.D. Anderson Cancer Center, Houston, Texas. Department of Gastrointestinal Medical Oncology The University of Texas MD Anderson Cancer Center Houston Texas 1Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas. MD Anderson Cancer Center, Texas Medical Center; Houston TX Authors' Affiliations: 1Discovery Oncology, 2Pharma Development, Roche Pharmaceuticals, Nutley, New Jersey; 3Department of Gastrointestinal Medical Oncology, MD Anderson Cancer Center, Houston, Texas; and 4Plexxikon Inc., Berkeley, California From The University of Texas MD Anderson Cancer Center, Houston, TX. 1Cancer Biology, Departments of; 2Gastrointestinal Medical Oncology, Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA 3The University of Texas MD Anderson Cancer Center, Houston, Texas. The University of Texas MD Anderson Cancer Center, Houston All authors: The University of Texas MD Anderson Cancer Center, Houston, TX. Michael J. Overman and Scott Kopetz, University of Texas MD Anderson Cancer Center, Houston, TX; Sara Lonardi, Istituto Oncologico Veneto, Istituto di Ricovero e Cura a Carattere Scientifico, Padova; Fabio Gelsomino, University Hospital of Modena, Modena; Massimo Aglietta, Institute for Cancer Research and Treatment of Candiolo, University of Torino Medical School, Turin, Italy; Ka Yeung Mark Wong, Sydney Medical School, University of Sydney, Sydney, New South Wales; Andrew Hill, Tasman Oncology Research... 2Department of Gastrointestinal Medical Oncology, and Department of Gastrointestinal Medical Oncology, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA Department of Gastrointestinal Medical Oncology; The University of Texas MD Anderson Cancer Center; Houston Texas 11University of Texas, MD Anderson Cancer Center, Houston, Texas. Arvind Dasari, The University of Texas MD Anderson Cancer Center, Houston, TX; Axel Grothey, The University of Tennessee West Cancer Center, Memphis, TN; and Scott Kopetz, The University of Texas MD Anderson Cancer Center, Houston, TX Ryan B. Corcoran, Eunice L. Kwak, and David P. Ryan, Massachusetts General Hospital Cancer Center and Harvard Medical School, Boston, MA; Chloe E. Atreya, Adil Daud, and Alan P. Venook, Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco; Omid Hamid, Angeles Clinic and Research Institute, Los Angeles, CA; Gerald S. Falchook, Sarah Cannon Research Institute at HealthONE, Denver; Wells A. Messersmith, University of Colorado Cancer Center and University of... Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston Department of Gastrointestinal Medical Oncology The University of Texas MD Anderson Cancer Center 1515 Holcombe Blvd. Houston TX 77030 USA Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA Department of Gastrointestinal Medical Oncology MD Anderson Durham NC 77030 USA Gastrointestinal Medical Oncology, Division of Cancer Medicine Department of Gastrointestinal Medical Oncology, University of Texas M. D. Anderson Cancer Center, Houston, TX. 4Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas; Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA MD Anderson Cancer Center, Houston, TX University of Texas M.D. Anderson Cancer Center, Houston, TX. 2Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas. Jeremy C. Jones, Lindsay A. Renfro, Ben Y. Zhang, Pashtoon M. Kasi, Jesse S. Voss, Alexis D. Leal, Joleen M. Hubbard, Benjamin R. Kipp, Robert R. McWilliams, and Axel Grothey, Mayo Clinic, Rochester, MN; Humaid O. Al-Shamsi, Scott Kopetz, and Robert A. Wolff, The University of Texas MD Anderson Cancer Center, Houston, TX; and Alexa B. Schrock, Andrew Rankin, James Sun, Jeffrey Ross, and Siraj M. Ali, Foundation Medicine, Cambridge, MA. From the University of Texas M.D. Anderson Cancer Center; Lyndon B. Johnson Hospital, Harris County Hospital District, Houston, TX; and Instituto do Cancer do Estado de Sao Paulo, Faculdade de Medicina, Universidade de Sao Paulo, Sao Paulo, Brazil. 4Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas. 7Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas. Department of Gastrointestinal Medical Oncology, M.D. Anderson Cancer Center , Houston, TX 77030, USA University of Texas MD Anderson Cancer Center, Houston, TX, USA 1Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas. Department of Gastrointestinal Medical Oncology, University of Texas MD Anderson Cancer Center, Houston 2Department of Surgical Oncology, Division of Surgery and Department of Molecular and Cellular Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas. 1The University of Texas MD Anderson Cancer Center, Houston, Texas. Division of Gastrointestinal Medical Oncology, The University of Texas, MD Anderson Cancer Center, Unit 426, 1515 Holcombe Blvd, Houston, TX 77030, USA Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA 2The University of Texas MD Anderson Cancer Center, Houston, Texas. Authors' Affiliations: Departments of 1Gastrointestinal Medical Oncology and 2Thoracic/Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas Junichi Shindoh, Evelyne M. Loyer, Scott Kopetz, Piyaporn Boonsirikamchai, Dipen M. Maru, Giuseppe Zimmitti, Steven A. Curley, Chusilp Charnsangavej, Thomas A. Aloia, and Jean-Nicolas Vauthey, The University of Texas MD Anderson Cancer Center, Houston, TX; Yun Shin Chun, Fox Chase Cancer Center, Philadelphia, PA. Department of Gastrointestinal (GI) Medical Oncology Division of Cancer Medicine The University of Texas MD Anderson Cancer Center Houston TX 77030 USA GI Medical Oncology, The University of Texas, M. D. Anderson Cancer Center, Houston, TX 77030, USA. Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 1Gastrointestinal Medical Oncology, Departments of; 2Cancer Biology, and From the Departments of Surgical Oncology, Gastrointestinal Medical Oncology, and Pathology, The University of Texas M. D. Anderson Cancer Center, Houston, TX Department of GI Medical Oncology, University of Texas M.D Anderson Cancer Center, Houston, Texas. |
Incoming Links
Showing number of triples: 1 to 430 of 430.